RKLB Stock Price Prediction 2026-2027: Can RKLB Reach $107 After the Space Force Deals

RKLB stock is back in focus after fresh Space Force awards, another strong earnings report, and rising analyst targets. RKLB stock now sits in a spot where the debate is less about whether Rocket Lab is growing and more about how much of that growth is already priced in. RKLB stock also remains one of the market’s more volatile space names because investors are balancing real revenue momentum against Neutron execution risk and cash burn. This article looks at whether $107 is a reasonable 2026-2027 price target and what has to go right for Rocket Lab to get there.

At a Glance

• Rocket Lab’s recent numbers are strong: Q1 2026 revenue reached $200.3 million, up 63.5% year over year, with backlog rising to $2.2 billion, according to GlobeNewswire.
• The newer 2026 framework is even more ambitious, with Q2 revenue reported at about $234.1 million, backlog at $2.36 billion, and more than 90 launch missions in backlog based on the provided event data.
• $107 matters more than the old $142 peak because it reflects a model-driven analyst target rather than a sentiment-heavy spike around the SpaceX IPO cycle.
• The biggest upside driver is Neutron. The biggest risk is still cash burn, especially with the announced Iridium acquisition creating added uncertainty.

Why $107 Is the Right Target to Examine Rather Than $142 All-Time High

For beginners, it helps to separate a trading spike from a valuation target. Rocket Lab’s roughly $142 high came during a period when commercial space stocks were being repriced higher around SpaceX-related excitement. That kind of move can happen fast, but it often includes a heavy sentiment premium. A $107 target is different. It is easier to analyze because it asks a more practical question: can Rocket Lab’s revenue, backlog, defense exposure, and medium-lift expansion justify another 33% to 45% gain from the recent post-earnings range of roughly $74 to $80?

That makes $107 the more useful benchmark for a real RKLB stock price prediction. It is not asking whether traders can get excited again for a week. It is asking whether the business can grow into a higher valuation. That difference matters, especially for investors who are not just looking at momentum but also at market cap, contract visibility, and future liquidity needs.

What the Space Force Contracts Specifically Add to the $107 Path

The clearest new bullish input is the pair of Space Force-related awards cited in the event information: $397 million and $266 million, or about $663 million combined. Those contracts matter for more than headline value. Government and defense contracts tend to improve revenue visibility, support backlog quality, and signal trust in Rocket Lab’s execution.

Rocket Lab was already showing better demand before these deals. According to Rocket Lab’s Q1 2026 release distributed through GlobeNewswire, backlog reached $2.2 billion. Alpha Spread also highlighted that the company signed 31 new Electron and HASTE contracts in Q1, with launch backlog topping 70 missions. The newer event figures push that trajectory further, with backlog at $2.36 billion and launch backlog above 90 missions. For RKLB stock, that supports the view that the company is no longer just a niche small-launch provider. It is increasingly being valued as a space and defense platform.

There is also a quality argument here. Revenue from defense customers is often seen as more durable than purely speculative commercial demand. If Rocket Lab executes these awards smoothly, the market may be willing to keep assigning a premium multiple to future revenue, which is one reason analysts remain broadly constructive.

The Neutron Rocket That Could Define the 2027 Price Story

If the Space Force contracts support the floor, Neutron is what could lift the ceiling. Electron built Rocket Lab’s reputation in small satellite launch, but Neutron is meant to move the company into medium-lift missions. That expands its addressable market and gives it access to higher-value government and commercial launch opportunities.

This is why Neutron dominates nearly every long-term RKLB stock forecast. Alpha Spread noted that Neutron had already signed five contracts as of Q1 2026, while management said first launch was still expected later in the year. At the same time, the reference material makes clear that timeline risk remains. Some market commentary suggests late 2026, while more cautious views point to further delays. That uncertainty is exactly why RKLB stock still trades like a high-growth, high-expectation name rather than a stable industrial company.

If Neutron flies successfully in Q4 2026, the 2027 story changes fast. Investors would likely begin valuing Rocket Lab on a larger launch opportunity set, not just on current Electron cadence and Space Systems revenue. If Neutron slips again, the stock may still hold up on backlog and defense demand, but the path to $107 becomes slower and more dependent on pure revenue execution.

The Backlog That Makes $107 Achievable Through Revenue Execution Alone

One reason bulls remain confident is that Rocket Lab is not relying on a single catalyst anymore. The business mix is getting broader. Substack analysis in the provided materials estimated backlog composition at roughly 58.5% Space Systems and 41.5% Launch. That matters because it lowers dependence on one rocket program or one launch schedule.

Even without a perfect Neutron timeline, the company’s recent financial trend is hard to ignore. Q1 2026 revenue reached $200.3 million, net loss narrowed to $45.0 million from $60.6 million a year earlier, and Q2 guidance at the time was $225 million to $240 million, with the midpoint about 12% above analyst expectations, according to Investing.com and GlobeNewswire. The event data then points to Q2 revenue around $234.1 million, up 62% year over year, with management guiding another record quarter in Q3.

For a beginner, backlog is similar to a booked pipeline. It is not the same as revenue, but it gives investors a view into future demand. Substack’s estimate that about 36% of backlog could convert to revenue over the next 12 months helps explain why some analysts see a route to full-year revenue near $900 million to $1 billion if Q3 and Q4 continue the current pace. That kind of scale would make a higher RKLB stock valuation easier to defend.

The Iridium Acquisition Wildcard That Could Accelerate or Delay $107

The most honest part of the RKLB stock debate is that not every catalyst is cleanly positive. The announced Iridium acquisition may strengthen Rocket Lab’s position in space systems and satellite communications, but the scale and financial impact were not fully confirmed in the supplied materials. That means investors are still guessing about integration costs, timing, and balance-sheet pressure.

This matters because Rocket Lab is still burning cash. The event information points to free cash flow of about negative $77.4 million per quarter. That is manageable for a fast-growing company if contract wins keep compounding and if liquidity remains strong, but it is still a real risk. GlobeNewswire said Rocket Lab exited Q1 with access to more than $2 billion in liquidity, which provides a buffer. Still, if Neutron development spending stays high and an acquisition adds further demands, the market could start worrying about dilution or a less efficient capital structure.

For stock investors, this is the equivalent of watching tokenomics in crypto. A strong project can still disappoint if future supply, funding needs, or capital allocation undermine per-share upside. In RKLB’s case, the business momentum looks strong, but the cash profile still deserves close attention.

The Three Scenarios That Map the Path to $107 and Beyond

Bullish scenario

In the strongest case, Neutron launches successfully in Q4 2026, Q3 and Q4 each set new revenue records, and full-year revenue lands near $950 million to $1 billion as suggested in the event framework. The Iridium deal integrates smoothly, and the Space Force awards deepen Rocket Lab’s relationship with government customers. In this case, RKLB stock could recover toward $95 to $105 by late 2026 and break above $107 in the first half of 2027, with a possible range of $107 to $120.

Base scenario

In a more moderate outcome, Neutron slips into the first half of 2027, but core launch and Space Systems growth remains healthy. Revenue keeps expanding near the current 60%-plus pace without massively beating guidance. Iridium adds friction in the near term but does not seriously damage the balance sheet. Under that setup, RKLB stock could trade around $85 to $95 by the end of 2026 and approach $107 later in 2027.

Cautious scenario

If Neutron is delayed again into the second half of 2027, cash burn worsens, or the Iridium acquisition proves heavier than expected, the market could cut its premium multiple. That could push RKLB stock back toward the $65 to $70 support area mentioned in the event material. In that case, $107 may not be realistic until 2028 or 2029.

How SpaceX's IPO Has Changed the Valuation Framework for All Space Stocks

Another reason $107 is not a wild target is sector repricing. The event material argues that the SpaceX IPO changed how investors look at commercial space companies, with more willingness to pay higher multiples for companies that combine launch, manufacturing, and defense exposure. Rocket Lab benefits from that broader rerating because it is one of the few public names with real revenue, growing backlog, and a recognizable product roadmap.

That said, Rocket Lab is not SpaceX. The competitive picture is more nuanced. SpaceX dominates heavy launch, while Rocket Lab remains stronger in small launch and is trying to expand upward with Neutron. So the bullish argument for RKLB stock is not that it beats SpaceX head-on. It is that it keeps building a differentiated position across launch services and space systems while the market assigns more value to the whole commercial space ecosystem.

Public’s analyst snapshot shows a Buy consensus as of August 11, 2026, while the supplied event data points to an average target near $111.13. That does not guarantee upside, but it shows that the market still sees room above current levels if execution stays on track.

Right now, $107 looks achievable but not automatic. The business has clearly strengthened, with faster revenue growth, a larger backlog, and better defense positioning than it had a year ago. But RKLB stock still needs two things to justify that target: disciplined cash management and a credible Neutron timeline. If Rocket Lab delivers both, the market may treat $107 as a stepping stone rather than the finish line.